Acta Dermatovenerologica Croatica is a premier journal dedicated to the fields of dermatology and venereology, published by the Croatian Dermatovenereological Society. Established in 1994, this journal has been a vital platform for disseminating research and advancements in the understanding and treatment of skin diseases and sexually transmitted infections. Although it is currently classified in the Q4 quartile for dermatology, infectious diseases, and miscellaneous medicine, it provides a unique opportunity for emerging researchers and seasoned professionals to contribute to a growing body of knowledge. Based in Zagreb, Croatia, the journal emphasizes free access to information that enhances clinical practices and scientific understanding among dermatologists and venereologists worldwide. As the journal approaches its 30th anniversary, it continues to aim for excellence in research quality, fostering collaboration, and innovating in the ever-evolving fields it represents.

The Hong Kong Journal of Dermatology & Venereology is a vital publication in the field of dermatology, dedicated to advancing research and clinical practice in this specialized area. Published by MEDCOM LTD, this journal has been a resourceful platform for dermatologists, researchers, and students since its inception in 2005, showcasing rigorous original research, comprehensive reviews, and case studies pertinent to both dermatology and venereology. Although currently categorized in Q4 of the dermatology quartiles, it serves as an important voice for the region, contributing to the global dialogue on skin and sexually transmitted diseases. With an ISSN of 1814-7453, the journal aims to bridge gaps in understanding and foster innovations that will lead to better patient care and outcomes. Readers can access its content, while researchers are encouraged to contribute to this growing body of knowledge that plays a critical role in enhancing dermatological practice in Hong Kong and beyond.

The JOURNAL OF DERMATOLOGICAL TREATMENT, published by TAYLOR & FRANCIS LTD, is a premier forum dedicated to advancing the field of dermatology through the dissemination of high-quality research. Since its inception in 1989, this journal has maintained a significant impact on the dermatological community, currently ranking in the top quartile (Q1) of the Dermatology category with an impressive Scopus ranking of #14 out of 142 journals, reflecting its reputation among peers and its contribution to the clinical and academic landscape. The journal shifted to Open Access in 2023, enhancing the accessibility of groundbreaking findings to researchers, clinicians, and students worldwide. With a commitment to publishing diverse articles, from innovative treatment modalities to comprehensive reviews, the JOURNAL OF DERMATOLOGICAL TREATMENT serves as an invaluable resource for professionals seeking to stay at the forefront of dermatological science in a rapidly evolving field.

Actas Dermo-Sifiliograficas, published by Elsevier España, stands as a pivotal resource in the realms of dermatology, histology, and pathology and forensic medicine. With its ISSN of 0001-7310 and E-ISSN 1578-2190, this esteemed journal has transitioned to an Open Access model since 2020, facilitating broader dissemination of impactful research. Operating from its Madrid headquarters, it has been a vital platform for scholarly exchange since its inception in 1945, continuing through its converged years until 2024. The journal holds a Q3 ranking in dermatology, histology, and pathology and forensic medicine as of 2023, reflecting its relevance in the academic community where it ranks 79th in dermatology and 126th in pathology among its peers. With a commitment to advancing knowledge and practice in its fields, Actas Dermo-Sifiliograficas serves as an essential repository for researchers, professionals, and students seeking to engage with the latest findings and innovative perspectives in skin and disease research.

DERMATOLOGY, an esteemed journal published by KARGER, is a vital resource in the field of dermatological research and clinical practice. Established in 1893, with its comprehensive coverage extending to 2024, this journal has earned its place as a leading publication, holding a prestigious Q1 quartile ranking in Dermatology and ranking 15th out of 142 in the Scopus Medicine - Dermatology category, reflecting its 89th percentile standing within the discipline. The journal aims to disseminate innovative research findings, critical reviews, and clinical studies that advance the understanding of skin disorders and their treatments. While primarily available through institutional subscriptions, DERMATOLOGY remains committed to enhancing accessibility and fostering international collaboration among researchers, professionals, and students in the dermatological community. Its rigorous peer-review process guarantees the highest quality of published works, making it an essential reference for those dedicated to advancing dermatological science and improving patient care.

ANAIS BRASILEIROS DE DERMATOLOGIA is a prestigious academic journal published by Elsevier Science Inc, specializing in the dynamic field of dermatology. With its Open Access model established in 2002, this journal ensures wide dissemination of research findings and facilitates collaboration within the dermatological community. Hailing from Brazil, it provides a platform for innovative research from both local and international contributors, spanning from its inception in 1963 to the current year, 2024. The journal positions itself as a vital resource in the dermatology sphere, currently ranked in the Q3 category for dermatology and holding a notable rank of 71 out of 142 in the Scopus rankings, placing it in the 50th percentile for its field. With a commitment to advancing knowledge and practice in dermatology, ANAIS BRASILEIROS DE DERMATOLOGIA is an essential read for researchers, professionals, and students eager to explore contemporary advancements and clinical practices.

JAMA Dermatology, an esteemed publication by the American Medical Association, is positioned at the forefront of dermatological research and clinical practice. With an ISSN of 2168-6068 and an E-ISSN of 2168-6084, this journal underscores a commitment to disseminating high-quality and impactful research within the field. Notably ranked Q1 in both Dermatology and Miscellaneous Medicine for 2023, JAMA Dermatology ranks among the top journals in its category, holding the impressive 3rd position out of 142 in Scopus's dermatology rankings, placing it in the 98th percentile. With converged years extending from 2013 to 2024, the journal emphasizes timely and critical advancements in dermatological science. Furthermore, as a champion of open access, it encourages a broad dissemination of knowledge, making essential research accessible to a wider audience. Researchers, professionals, and students alike will find JAMA Dermatology to be an invaluable resource for the latest findings, innovative therapies, and in-depth reviews that shape the future of dermatological health.

Egyptian Journal of Dermatology and Venereology is a premier peer-reviewed journal dedicated to advancing the fields of dermatology and venereology. Published by Wolters Kluwer Medknow Publications, this journal provides a vital platform for researchers, clinicians, and healthcare professionals to share cutting-edge research, case studies, and reviews that contribute to the understanding and treatment of skin and sexually transmitted diseases. With an ISSN of 1110-6530 and an E-ISSN of 2314-7407, the journal ensures global accessibility and visibility of its content, fostered by its commitment to high-quality publications. Although it operates with restricted access, the Egyptian Journal of Dermatology and Venereology remains an essential resource for practitioners and academics alike, supporting the dissemination of knowledge and innovation in skin health. Situated in Mumbai, India, the journal reflects a diverse pool of contributions that enrich our understanding of dermatological practices and principles on an international scale.

Annals of Dermatology is a prestigious academic journal published by the Korean Dermatological Association, focusing on the latest research and advancements in the field of dermatology. With a commitment to advancing knowledge in skin health and disease, this journal serves as a vital resource for researchers, clinicians, and students working in dermatology and related disciplines. Since its inception in 1989, it has evolved to consolidate its position in the academic community, boasting a Q2 ranking in the 2023 Dermatology category and a Scopus rank of #87 out of 142, placing it in the 39th percentile. Although it operates under a subscription model, the journal's impact factor reflects its significance in advancing dermatological research, attracting innovative studies and reviews that shape clinical practice. With a publication history extending from 1989 to 1996 and then from 2008 to the present, Annals of Dermatology continues to be an essential publication for those devoted to improving skin health.

CLINICAL AND EXPERIMENTAL DERMATOLOGY is a prominent journal in the field of dermatology, published by Oxford University Press. With an ISSN of 0307-6938 and an E-ISSN of 1365-2230, this journal has been a vital resource for researchers and practitioners since its inception in 1976. Recognized as a Q2 journal within the category of dermatology for 2023, it holds a respectable position, ranking #54 among 142 journals in this discipline, placing it in the 62nd percentile on Scopus. The journal is dedicated to publishing high-quality research that spans clinical and experimental aspects of dermatological science, making it an essential source of knowledge for advancing understanding and treatment of skin disorders. Although it operates on a traditional subscription model without open access options, its contributions to the field are significant, influencing both clinical practices and academic research. Researchers, clinicians, and students alike will find vital insights and contemporary themes presented in its pages, supporting ongoing education and innovation in dermatology.